Ultra-early warning enzymatic test for prescreening 100+ diseases, with a primary focus on oncological risks, detecting abnormalities up to 1,000 times earlier than conventional markers, already at the level of 1 million tumor cells. 99.9% system robustness, up to 98.6% sensitivity, and 94–96%...
